Most Recent Articles by Natasha Persaud
At 5 years, 59.3% of patients treated with sunitinib were free from recurrence versus 51.3% who received placebo.
Febuxostat may increase the risk for heart-related death.
Updated recommendations lower the blood pressure threshold for a hypertension diagnosis from 140/90 to 130/80 mm Hg.
ESRD patients with SHPT undergoing surgery had a 26% lower risk for all-cause mortality compared with medical management.
The model was based on 6 variables readily obtained at hospital discharge.
More Articles by Natasha Persaud
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)